ZA975805B - Virginiamycin mixture - Google Patents

Virginiamycin mixture

Info

Publication number
ZA975805B
ZA975805B ZA975805A ZA975805A ZA975805B ZA 975805 B ZA975805 B ZA 975805B ZA 975805 A ZA975805 A ZA 975805A ZA 975805 A ZA975805 A ZA 975805A ZA 975805 B ZA975805 B ZA 975805B
Authority
ZA
South Africa
Prior art keywords
virginiamycin
mixture
virginiamycin mixture
Prior art date
Application number
ZA975805A
Other languages
English (en)
Inventor
James William Carson
Frederic William Chapin
Charles Hollett Fahrenholz
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA975805B publication Critical patent/ZA975805B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/195Antibiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/424Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15Depsipeptides; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
ZA975805A 1996-07-01 1997-06-30 Virginiamycin mixture ZA975805B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2051296P 1996-07-01 1996-07-01

Publications (1)

Publication Number Publication Date
ZA975805B true ZA975805B (en) 1998-12-30

Family

ID=21799022

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA975805A ZA975805B (en) 1996-07-01 1997-06-30 Virginiamycin mixture

Country Status (15)

Country Link
EP (2) EP0906098A1 (ja)
JP (2) JPH11514001A (ja)
KR (1) KR100395607B1 (ja)
AP (1) AP9701038A0 (ja)
AU (1) AU2786297A (ja)
BR (1) BR9710019A (ja)
CA (1) CA2259298A1 (ja)
DZ (1) DZ2256A1 (ja)
IL (1) IL127565A0 (ja)
MA (1) MA24239A1 (ja)
NZ (1) NZ333301A (ja)
PL (1) PL330961A1 (ja)
TR (1) TR199802741T2 (ja)
WO (1) WO1998000136A1 (ja)
ZA (1) ZA975805B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7867514B2 (en) * 2000-05-24 2011-01-11 Otsuka Pharmaceutical Co., Ltd. Method for stabilizing preparation
WO2005013964A1 (ja) * 2003-08-08 2005-02-17 Ajinomoto Co., Inc. ナテグリニド含有製剤
US7498309B2 (en) * 2003-11-29 2009-03-03 Sangstat Medical Corporation Pharmaceutical compositions for bioactive peptide agents
US9240259B2 (en) 2011-10-07 2016-01-19 E I Du Pont De Nemours And Company Liquid compositions used as insulating and heat transfer means, electrical devices containing said compositions and preparation method for such compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE819863A (fr) * 1974-09-13 1975-03-13 Compositions d'antibiotiques du type virginiamycine pour administration orale.
US5266347A (en) * 1992-01-28 1993-11-30 Ducoa L.P. Antibiotic biomass animal feed compositions
DE69322764T2 (de) * 1992-10-09 1999-05-06 Kanegafuchi Chemical Ind Herstellungsmethode für feines granulat
IL121821A (en) * 1993-02-17 2000-02-17 Rhone Poulenc Rorer Sa Process for purifying a group A minority component of streptogramin some such purified components and their uses
WO1995011598A1 (en) * 1993-10-26 1995-05-04 Lachlan Macsmith Pelletized high nutrient feed for ruminants
KR100819863B1 (ko) * 2001-09-03 2008-04-07 엘지.필립스 엘시디 주식회사 유량측정장치

Also Published As

Publication number Publication date
BR9710019A (pt) 1999-08-10
KR20000022446A (ko) 2000-04-25
JP2002316931A (ja) 2002-10-31
AU2786297A (en) 1998-01-21
EP1147770A1 (en) 2001-10-24
JPH11514001A (ja) 1999-11-30
EP0906098A1 (en) 1999-04-07
PL330961A1 (en) 1999-06-21
CA2259298A1 (en) 1998-01-08
KR100395607B1 (ko) 2004-01-31
NZ333301A (en) 1999-09-29
MA24239A1 (fr) 1997-12-31
AP9701038A0 (en) 1997-07-31
DZ2256A1 (fr) 2002-12-18
IL127565A0 (en) 1999-10-28
TR199802741T2 (xx) 1999-03-22
WO1998000136A1 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
HRP970308B1 (en) Peptide derivatives
HK1015383A1 (en) Peptide derivatives
GB9624562D0 (en) Peptide derivatives
PL327639A1 (en) Covering
IL127565A0 (en) Virginiamycin mixture
GB9613705D0 (en) Novel peptides
ZA977005B (en) Therapeutic uses
GB9622890D0 (en) Peptide compounds
PL330823A1 (en) Improved autoradiohraphy
GB9605904D0 (en) Peptides
GB9608430D0 (en) Peptides
SG55039A1 (en) Peptides
GB9606765D0 (en) Peptides
GB9626362D0 (en) Peptides
GB9625227D0 (en) Peptides
GB9612648D0 (en) Peptides
PL314371A1 (en) Longwall-type combined cutter-loader
GB9611881D0 (en) Peptide derivatives
GB9603855D0 (en) Peptide derivatives
GB9709607D0 (en) Peptide derivatives
SI0882066T1 (en) Peptide derivatives
GB9617889D0 (en) Gas preparation
GB9614121D0 (en) Combined medicament
HU1160U (en) Chess-piece set
GB9613237D0 (en) Structures